Product

Chidamide + Venetoclax + Azacitidine (VAC)

1 clinical trial

1 indication

Indication

Acute Myeloid Leukemia

Clinical trial

A Clinical Study of Chidamide in Combination With Venetoclax and Azacitidine (VAC) for Patients With Acute Myeloid Leukemia Who Did Not Achieve CR/CRi/MLFS (PR or NR) With One Cycle of Venetoclax and Azacitidine (VA).

Status: Recruiting, Estimated PCD: 2026-12-01